Max Robotics — Global Service Robot Directory + US Certification

About

Dr. Neil Fleshner is a leading urologic oncologist whose research has centered on optimizing treatment outcomes and quality of life for men with genitourinary cancers, particularly prostate cancer. His work critically evaluates surgical innovations, such as comparing robotic-assisted versus open radical prostatectomy, where his studies have examined not only oncologic control but also the crucial impact on patients' health-related quality of life. Dr. Fleshner has also contributed to shaping clinical practice by investigating the technical implications of surgical approaches, including whether transperitoneal laparoscopic prostatectomy alters the pelvic anatomy for subsequent radiotherapy. Beyond individual studies, he has helped define the broader landscape of genitourinary cancer management, addressing key controversies across the entire treatment continuum from diagnosis through survivorship. His research, cited in influential clinical guidelines and discussions, reflects a commitment to evidence-based, patient-centered care. Through these contributions, Dr. Fleshner has advanced the understanding of how surgical technique and treatment sequencing affect both cancer control and the daily lives of patients, making him a respected voice in the field of urologic oncology.